Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
29,702,841
-
Share change
-
-2,822,216
-
Total reported value
-
$273,260,055
-
Put/Call ratio
-
301%
-
Price per share
-
$9.20
-
Number of holders
-
130
-
Value change
-
-$28,688,572
-
Number of buys
-
59
-
Number of sells
-
68
Institutional Holders of INSYS THERAPEUTICS INC NEW - COM NEW (INSYQ) as of Q4 2016
As of 31 Dec 2016,
INSYS THERAPEUTICS INC NEW - COM NEW (INSYQ) was held by
130 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,702,841 shares.
The largest 10 holders included
SCOPIA CAPITAL MANAGEMENT LP, ORBIMED ADVISORS LLC, VANGUARD GROUP INC, BlackRock Fund Advisors, Folger Hill Asset Management LP, BlackRock Institutional Trust Company, N.A., DIMENSIONAL FUND ADVISORS LP, Invesco Ltd., Bank of New York Mellon Corp, and STATE STREET CORP.
This page lists
130
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.